Sachs Associates would like to say that we have enjoyed hosting you in person and virtually and thank those who participated in our Sachs Autumn Life Sciences Week, which incorporated the 11th Annual HealthTech Investment Forum (#Sachs_HTIF) and the 24th Annual Biotech in Europe Forum (#Sachs_BEF). A special thank you goes to the excellent lineup of sponsors, chairs, panellists, and presenters who made such a broad and interesting programme possible and to those who participated in person and during the virtual week.
The Life Sciences Week has proven to be successful in supporting our community with 589 delegates from 32 countries and over 2500 in-person & online meetings completed.
Publicly available recordings of the sessions and presentations that took place during the event will be added once the event portal closes (after the 25th of October) on the SachsTV YouTube channel.
We are looking forward to welcoming you again at our future events!
SILVER SPONSOR:
BRONZE SPONSORS:
CONTRIBUTING SPONSOR:
RECEPTION SPONSOR:
Presenting Companies Included:
Exhibitors Included:
Confirmed Keynote Speakers Included:
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Laura Lane
VP Lilly Ventures - Head of Europe, Eli Lilly and Company
Lukas Engelberger
State Councillor, Department of Public Health, Canton of Basel-Stadt
Renée Aguiar-Lucander
CEO, Hansa Biopharma AB
Speakers and Chairs Included:
Antoine Boulanger
Partner, Apollo Health Ventures
Esteban Pombo-Villar
Board Member, TargImmune Therapeutics AG
François Thomas
Operating Partner, Quadrille Capital
Gregory Rall
Deputy Head, Innovation & Technology, InvestHK
Keld Flintholm Jørgensen
SVP & CBO, H. Lundbeck A/S
Marianne Uteng
Managing Director, Novartis Venture Fund
Marie Schroeder
Vice President, Novo Holdings A/S
Rainer Strohmenger
Managing Partner, Wellington Partners
Sarah Holland
President of Swiss Healthcare Licensing Group & CBO, CDR-Life AG
Shelley Margetson
Managing Partner, V-Bio Ventures BV
Stephanie Léouzon
Managing Director & Vice Chair of European Healthcare Investment Banking, Stifel
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Alessandra Polara
Senior Director, Global BD, F. Hoffmann-La Roche AG
Alex Blyth
CEO, LIfT BioSciences Ltd.
Anders Bue Klein
Co-Founder & CEO, Ousia Pharma ApS
Antti Vuolanto
CEO, Herantis Pharma Plc
Aram Mangasarian
CEO, TME Pharma
Berthold Hinzen
Global Head BD&L Transactions Immunology, Novartis AG
Christoph Korpus
Director Global Business Development & Licensing Oncology, Merck KGaA, Darmstadt, Germany
Cindy Daniel
Head of Unit - Life Sciences & Healthcare - Equity Investments, European Investment Fund
Darren Ji
Co-Founder, Chairman & CEO, Elpiscience Biopharmaceuticals Co. Ltd.
Dimitrios Weedon-Topalopoulos
Managing Director, OrbiMed Advisors LLC
Dragan Grabulovski
Founder & CEO, Grabulovski Consulting Services GmbH
Edward van Wezel
Managing Partner, BioGeneration Ventures (BGV)
Eric Halioua
Executive Chairman, Ervimmune
Federico Bolognani
Chief Medical Officer, IAMA Therapeutics S.r.l.
Frank Grams
Chief Commercial Officer, Partex N.V.
Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences | Greater China Managing Partner, L.E.K. Consulting
Hubert Birner
Managing Partner, TVM Capital Life Science
Isabella Schidrich
Senior Managing Director, Listings EMEA,
Jeremy Griggs
Executive Director, Search & Evaluation, GSK
Jesus Baena
BD&L Transactions Oncology Director, Novartis AG
Josua Jordi
Chief Scientific Officer, Tanai Therapeutics
Katharina Kreymborg
SVP, Curie.Bio
Konstantin Petropoulos
CEO, Secarna Pharmaceuticals GmbH & Co. KG
Kristian Tryggvason
Founder & CEO, Alder Therapeutics AB
Laurent Jacqueroud
BD & Investment Director, Cumulus Oncology
Louise S. Dalbøge
Chief Science Officer, Gubra A/S
Lynn Durham
Founder & CEO, STALICLA SA
Magne Stoknes
Principal, Novo Holdings A/S
Marina Udier
CEO, Nouscom AG
Matthieu Coutet
Partner, Sofinnova Partners
Michael Kingston
Managing Director, Global Co-Head of Biopharma & Co-Head of North American Healthcare, Lazard Ltd.
Michael Altorfer
CEO, Swiss Biotech Association
Michael Hübner
Director External Scientific Innovation, Johnson & Johnson Innovation LLC
Nigel Sheail
Partner, Versant Ventures
Olav Zilian
Medical Advisor, FluoSphera SA
Patrick Schwab
Senior Director, AI & Machine Learning, GSK
Paul Hermant
Partner, Bird & Bird (Belgium) LLP
Paul Bravetti
CEO, Brenus Pharma
Peter Braun
CEO, TargImmune Therapeutics AG
Renée Aguiar-Lucander
CEO, Hansa Biopharma AB
Rianne Ellenbroek
Principal, BioGeneration Ventures
Ricardo Pacheco
Strategic Partnering, BD&L Director, Insilico Medicine
Richard Ward
Executive Director, Oncology Search & Evaluation, GSK
Rupert Haynes
CEO, Avata Biosciences
Sam Fazeli
Head of Research, Global Industries & Senior Pharmaceuticals Analyst, Bloomberg Intelligence
Sanja Tomovska
Co-Founder & CEO, Quant Biomarkers AG
Seth Goldblum
SVP - Corporate Development, Cullgen Inc.
Stephan Emmerth
Director, BaseLaunch
Stephane Degove
CEO, Atamyo Therapeutics SAS
Tamas Schweighoffer
Co-Founding Partner, Forty51 Ventures AG
Victoria English
Co-Founder & Editor, Evernow Publishing Ltd, publisher of MedNous
Ximing Ding
Principal, Pureos Bioventures